Allied Healthcare Products
AHPI
AHPI was delisted on the 2nd of February, 2023.
18 hedge funds and large institutions have $2.11M invested in Allied Healthcare Products in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 4 closing their positions.
5% less funds holding
Funds holding: 19 → 18 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
65% less capital invested
Capital invested by funds: $5.95M → $2.11M (-$3.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$161K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$36.6K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$14.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$626K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$424K |
| 3 |
Barclays
London,
United Kingdom
|
-$231K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$78.8K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$35.5K |
AHPI Hedge Fund Activity: Q3 2020 in Review
18 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q3 2020, worth a combined $2.11M — down 65% from $5.95M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AHPI and 3 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 5 added.
The largest buyer was Morgan Stanley, adding an estimated $161K. The largest seller was Renaissance Technologies, cutting an estimated $626K.
- 18 institutional investors held Allied Healthcare Products (AHPI) as of Q3 2020, down from 19 in Q2 2020.
- Funds reported $2.11M of Allied Healthcare Products stock for Q3 2020, down 65% quarter-over-quarter.
- 3 funds opened new Allied Healthcare Products positions in Q3 2020 and 4 closed out, a net change of -1 holder.
- The largest Allied Healthcare Products buyer in Q3 2020 was Morgan Stanley, an estimated $161K added.
- The largest Allied Healthcare Products seller in Q3 2020 was Renaissance Technologies, an estimated $626K sold.
Based on aggregated 13F filings for Q3 2020.